Leveraging AI for Transformative Drug Discovery and Development

Annie Yim, PhD, from Boehringer Ingelheim, presented how AI and machine learning are revolutionizing the drug discovery pipeline, from target identification to clinical trials and manufacturing. She highlighted real-world applications of AI, like patient recruitment optimization, quality control and omics data analysis, which are advancing efficiency and reducing costs across the pharmaceutical industry.